african
swine
fever
viru
asfv
causal
agent
highlycontagi
fatal
diseas
domest
pig
lead
seriou
socioeconom
consequ
affect
countri
neither
antivir
drug
effect
vaccin
avail
studi
new
antiasfv
molecul
urgent
need
recent
shown
asfv
type
ii
topoisomeras
asfvtopo
ii
inhibit
sever
fluoroquinolon
bacteri
dna
topoisomeras
inhibitor
rais
idea
viral
enzym
potenti
target
drug
develop
asfv
report
genistein
hamper
asfv
infect
noncytotox
concentr
vero
cell
porcin
macrophag
interestingli
antivir
activ
isoflavon
previous
describ
topo
ii
poison
eukaryot
maxim
ad
cell
middlephas
infect
hpi
disrupt
viral
dna
replic
block
transcript
late
viral
gene
well
synthesi
late
viral
protein
reduc
viral
progeni
singl
cell
electrophoresi
analysi
reveal
presenc
fragment
asfv
genom
cell
expos
genistein
suggest
molecul
also
act
asfvtopo
ii
poison
revers
inhibitor
antivir
effect
detect
genistein
ad
entri
phase
asfv
infect
molecular
dock
studi
demonstr
genistein
may
interact
four
residu
atpbind
site
asfvtopo
ii
show
bind
affin
kcalmol
atp
kcalmol
emphas
idea
viral
enzym
essenti
role
viral
genom
replic
good
target
drug
develop
asfv
african
swine
fever
viru
asfv
member
famili
asfarvirida
envelop
viru
contain
kbp
doublestrand
dna
encod
gene
caus
agent
african
swine
fever
asf
highli
contagi
transboundari
diseas
domest
wild
pig
depend
circul
viral
strain
clinic
sign
may
vari
highli
lethal
form
mortal
subclin
asymptomat
form
gallardo
et
al
although
asf
erad
europ
except
sardinia
reemerg
caucasu
region
spread
russian
feder
ukrain
belaru
estonia
latvia
lithuania
poland
moldova
caus
seriou
socioeconom
impact
affect
countri
gallardo
et
al
fact
vaccin
avail
make
antivir
research
strong
prioriti
asfv
field
zakaryan
revilla
flavonoid
polyphenol
secondari
metabolit
found
veget
fruit
seed
nut
spice
stem
well
red
wine
tea
broad
spectrum
biolog
activ
neuroprotect
antioxid
antiinflammatori
anticanc
antibacteri
romano
et
al
interestingli
one
mani
biolog
effect
flavonoid
antivir
activ
exampl
apigenin
extract
ocimum
basilicum
show
potent
antivir
activ
adenovirus
hepat
b
viru
chiang
et
al
wherea
quercetin
demonstr
dosedepend
antivir
activ
herp
simplex
viru
lyu
et
al
japanes
enceph
viru
johari
et
al
hepat
c
viru
vitro
roja
et
al
influenza
subtyp
vivo
cho
et
al
similarli
genistein
shown
inhibit
hiv
infect
rest
cell
interfer
hivmedi
actin
dynam
guo
et
al
also
disrupt
replic
avian
leucosi
viru
rotaviru
herp
simplex
viru
vitro
argenta
et
al
huang
et
al
qian
et
al
recent
found
two
flavonoid
apigenin
genistein
exert
inhibitori
effect
replic
asfv
vitro
hakobyan
et
al
howev
antiasfv
mechan
genistein
investig
report
dosedepend
inhibit
asfv
vero
cell
porcin
alveolar
macrophag
also
demonstr
major
antivir
effect
observ
genistein
ad
time
point
coincid
viral
dna
synthesi
suggest
event
could
impair
genistein
experi
confirm
genistein
inhibit
viral
dna
replic
protein
synthesi
final
base
result
obtain
comet
assay
molecular
dock
propos
mechan
action
antivir
activ
genistein
vero
african
green
monkey
kidney
cell
maintain
eagl
minimum
essenti
medium
emem
lonza
belgium
supplement
fetal
bovin
serum
fb
mm
lglutamin
iuml
penicillin
streptomycin
sigmaaldrich
germani
prepar
porcin
alveolar
macrophag
done
previous
describ
carrascosa
et
al
alveolar
cell
cultur
dulbecco
modifi
eagl
medium
dmem
sigmaaldrich
germani
supplement
fb
mm
lglutamin
iuml
penicillin
streptomycin
experi
vero
cell
veroadapt
asfv
strain
use
asfv
strain
viral
titrat
measur
cytopath
effect
cpebas
assay
vero
cell
serial
dilut
supernat
titer
calcul
endpoint
method
express
tcid
ml
porcin
alveolar
macrophag
infect
virul
asfv
strain
titrat
strain
perform
hemadsorpt
assay
previous
describ
carrascosa
et
al
titer
express
hadu
ml
genistein
purchas
cayman
chemic
germani
dissolv
dimethyl
sulfoxid
dmso
mm
stock
resuspend
emem
without
fb
indic
concentr
use
time
experi
dilut
cell
cultur
medium
perform
final
concentr
dmso
exceed
v
v
cytotox
genistein
evalu
vero
cell
porcin
alveolar
macrophag
mtt
assay
confluent
cell
cell
cultur
plate
cellwel
treat
increas
concentr
genistein
rang
treat
cell
incub
h
co
incub
medium
remov
mtt
solut
sigmaaldrich
germani
ad
cell
incub
h
ad
mtt
solut
follow
purpl
formazan
extract
mtt
solvent
colorimetr
measur
perform
micropl
reader
nm
tecan
spectra
ii
switzerland
percentag
viabl
cell
calcul
concentr
od
od
c
od
od
c
correspond
absorb
treat
control
cell
respect
cell
cytotox
cc
determin
concentr
compound
caus
cellular
death
cytotox
final
concentr
dmso
also
measur
vero
cell
cell
cultur
plate
cellwel
macrophag
cellwel
plate
incub
asfv
tcid
cell
asfv
strain
hadu
cell
genistein
ad
decreas
concentr
h
viru
inoculum
remov
new
medium
test
compound
ad
viru
collect
hpi
titrat
cpebas
assay
assay
vero
cell
cell
cultur
plate
cellwel
macrophag
cellwel
plate
design
h
accord
time
asfv
infect
pretreat
assay
vero
cell
macrophag
treat
genistein
h
infect
asfv
tcid
cell
asfv
hadu
cell
respect
cotreat
assay
cell
expos
genistein
time
asfv
ad
cell
posttreat
assay
cell
infect
asfv
compound
ad
h
infect
viru
control
asfv
ad
respect
well
h
plate
incub
co
h
viru
collect
titrat
cpebas
assay
assay
attach
assay
vero
cell
cell
cultur
plate
cellwel
incub
asfv
tcid
cell
genistein
h
allow
viru
bind
prevent
viral
intern
unbound
viru
genistein
discard
cell
thoroughli
wash
pb
emem
contain
fb
ad
plate
switch
incub
h
intern
assay
cell
incub
asfv
h
unbound
viru
discard
cell
thoroughli
wash
pb
temperatur
shift
allow
viru
entri
proceed
test
compound
ad
h
remov
h
follow
temperatur
shift
cell
thoroughli
wash
pb
fresh
emem
ad
time
point
cell
shift
consid
h
h
viru
collect
titrat
cpebas
assay
viru
suspens
contain
tcid
well
particl
incub
volum
solut
genistein
h
vero
cell
cell
cultur
plate
cellwel
infect
dilut
treat
viral
suspens
elimin
potenti
effect
genistein
asfv
infect
h
adsorpt
cell
thoroughli
wash
pb
emem
contain
fb
ad
h
viru
titer
analyz
cpebas
assay
viral
dna
measur
done
previous
describ
hakobyan
et
al
briefli
vero
cell
macrophag
grown
coverslip
cellwel
infect
asfv
tcid
cell
asfv
hadu
cell
respect
expos
genistein
hpi
hpi
hpi
cell
fix
ethanol
solut
min
stain
fresh
schiff
reagent
dna
hydrolysi
n
hydrochlor
acid
min
method
feulgen
dna
content
viral
factori
measur
computerequip
microscopecytomet
smp
carl
zeiss
germani
nm
express
integr
optic
densiti
iod
cytometr
equival
dna
content
measur
carri
viral
factori
per
sampl
vero
cell
porcin
macrophag
grown
mm
dish
infect
strain
moi
asfv
moi
indic
expos
genistein
sigmaaldrich
concentr
adsorpt
period
h
follow
step
protein
extract
mockinfect
infect
genisteintr
infectedcel
wash
twice
pb
lyse
icecold
modifi
ripa
buffer
mm
tri
mm
nacl
vv
wv
sodium
deoxycol
wv
sd
ph
supplement
proteaseinhibitor
cocktail
complet
mini
edtafre
roch
phosphataseinhibitor
cocktail
phosstop
roch
clarifi
wholecel
lysat
harvest
hpi
subject
sdspage
gel
electrophoresi
use
wv
polyacrylamid
separ
gel
biorad
transfer
pore
diamet
nitrocellulos
membran
whatman
schleider
schuell
electroblot
blot
membran
block
phosphatebuff
salin
plu
vv
pbst
contain
wv
bsa
sigmaaldrich
h
rt
thereaft
incub
specif
primari
antibodi
rt
h
follow
wash
step
pbst
min
membran
incub
appropri
secondari
antibodi
conjug
hrp
h
rt
final
wash
step
pbst
min
perform
protein
detect
chemiluminesc
detect
kit
pierc
ecl
western
blot
substrat
thermo
scientif
amersham
hyperfilm
ecl
ge
healthcar
use
load
control
immunoblot
analysi
follow
primari
antibodi
use
inhous
produc
swine
antiasfv
serum
ingenasa
madrid
spain
cell
signal
technolog
dilut
perform
block
solut
dilut
incub
accord
manufactur
recommend
follow
hrpconjug
antibodi
incub
min
period
user
improv
concentr
antiswin
igg
antirabbit
igg
antimous
igg
jackson
immunoresearch
lab
west
grove
usa
qrtpcr
analysi
perform
previous
describ
frouco
et
al
briefli
total
rna
extract
asfvinfect
porcin
macrophag
moi
differ
time
point
infect
use
rneasi
mini
kit
rnasefre
dnase
set
qiagen
firststrand
cdna
synthes
total
rna
use
superscript
ii
first
strand
synthesi
system
invitrogen
analyz
duplic
qrtpcr
realtim
pcr
reaction
mixtur
contain
templat
cdna
forward
revers
primer
nm
tabl
maxima
sybr
greenrox
qpcr
master
mix
thermo
scientif
steril
water
final
volum
per
tube
thermal
cycl
condit
initi
denatur
step
min
follow
cycl
qrtpcr
analysi
perform
use
realtim
pcr
system
appli
biosystem
mrna
level
viral
gene
refer
gene
cyclophilin
quantifi
use
standard
curv
differ
plasmid
pgem
pgem
pgem
pgem
teasycyclophilin
data
qrtpcr
reaction
show
amplif
effici
use
level
dna
damag
evalu
standard
alkalin
comet
assay
tice
et
al
freita
et
al
vero
cell
cell
infect
asfv
tcid
cell
expos
genistein
hpi
hpi
hpi
addit
noninfect
nonexpos
noninfect
expos
infect
nonexpos
cell
cultur
use
control
mixtur
cell
low
melt
point
agaros
place
slide
precoat
normal
melt
point
agaros
cell
lyse
immers
slide
lysi
solut
nacl
mm
na
edta
mm
tri
triton
ph
min
incub
freshli
made
alkalin
buffer
mm
naoh
mm
na
edta
ph
min
electrophoresi
tank
dna
unwind
electrophores
min
v
cm
buffer
slide
neutral
tri
ph
min
stain
ethidium
bromid
imag
examin
fluoresc
microscop
zeiss
germani
dna
damag
assess
use
comet
assay
iv
softwar
percept
instrument
uk
total
cell
analyz
three
replic
slide
sampl
dna
tail
use
quantifi
dna
damag
homolog
model
asfvtopo
ii
tertiari
structur
conduct
use
icmpro
program
packag
full
refin
option
icm
forc
field
abagyan
et
al
amino
acid
sequenc
asfvtopo
ii
retriev
uniprotkb
id
use
homolog
model
close
homologu
avail
crystal
structur
protein
databank
identifi
use
icm
crystal
structur
topo
ii
dimer
saccharomyc
cerevisia
pdb
crystal
structur
human
topo
pdb
highest
similar
coverag
rel
asfvtopo
ii
avail
homologu
crystal
structur
identifi
suitabl
templat
candid
homolog
model
determin
accuraci
obtain
model
procheck
program
use
laskowski
et
al
sinc
asfvtopo
ii
bind
two
mg
ion
per
subunit
cofactor
conduct
induc
fit
dock
two
mg
ion
asfvtopo
ii
monom
model
sequenc
primer
use
qrtpcr
analysi
primer
name
sequenc
sens
sequenc
orient
proteinprotein
dock
obtain
asfvtopo
ii
monom
tertiari
structur
carri
repeat
time
use
fast
fourier
transform
fft
dock
method
icm
totrov
abagyan
follow
refin
procedur
best
obtain
dimer
model
final
refin
asfvtopo
ii
dimer
model
solvat
water
follow
neutral
system
subject
sd
abnr
minim
algorithm
charmm
forc
field
use
charmm
program
brook
et
al
structur
atp
genistein
obtain
molcart
compound
databas
icm
induc
fit
dock
atp
genistein
asfvtopo
ii
dimer
model
use
icm
explicit
group
dock
method
perform
fernandezrecio
et
al
dock
compound
repeat
time
dock
result
evalu
icm
score
valu
best
interact
model
bind
energi
also
evalu
schapira
et
al
visual
analysi
asfvtopo
ii
dimer
model
dock
result
perform
use
icmpro
softwar
packag
use
linux
oson
comput
cluster
imb
na
ra
hpc
msu
cc
calcul
linear
regress
analysi
doserespons
curv
gener
data
ic
calcul
nonlinear
regress
analysi
doserespons
curv
gener
data
data
express
mean
sd
three
independ
experi
data
analyz
nonparametr
mannwhitney
u
test
comet
assay
student
ttest
assay
p
consid
statist
signific
cytotox
genistein
measur
base
mtt
assay
carri
vero
cell
porcin
alveolar
macrophag
expos
genistein
day
time
interv
chosen
viru
yield
reduct
also
measur
incub
period
complet
cpe
observ
shown
fig
genistein
inhibit
vero
cell
growth
concentr
cytotox
concentr
cell
surviv
cc
cytotox
effect
genistein
macrophag
lower
vero
cell
cc
fig
cell
treat
dmso
concentr
less
vv
display
cytotox
chang
data
shown
establish
whether
genistein
possess
antivir
activ
asfv
dosedepend
manner
treat
asfvinfect
vero
cell
genistein
differ
concentr
rang
shown
fig
genistein
exert
antiasfv
effect
dosedepend
manner
ic
si
reduc
viral
yield
log
tcid
ml
tcid
ml
concentr
p
exhibit
signific
antivir
effect
concentr
lower
sinc
compound
show
potent
inhibitori
activ
concentr
decid
perform
evalu
use
concentr
next
conduct
timeofaddit
assay
evalu
effect
genistein
specif
step
asfv
life
cycl
therefor
compound
ad
h
prior
infect
pretreat
h
postinfect
hpi
posttreat
data
shown
fig
suggest
genistein
exhibit
potent
antiasfv
activ
ad
hpi
reduc
viral
titer
log
p
strong
antivir
effect
also
observ
genistein
ad
hpi
p
contrast
genistein
show
inhibitori
effect
asfv
infect
cell
treat
infect
taken
togeth
result
indic
earli
middl
stage
asfv
infect
disrupt
genistein
base
result
timeofaddit
assay
specul
genistein
could
act
either
virucid
agent
block
viral
entri
therefor
studi
effect
genistein
viral
entri
well
extracellular
viral
particl
virucid
activ
shown
fig
neither
antientri
virucid
effect
genistein
detect
viru
yield
quantifi
differ
hour
postinfect
sinc
major
antiasfv
effect
occur
genistein
ad
hpi
coincid
time
earli
stage
viral
dna
synthesi
rojo
et
al
et
al
hypothes
genistein
may
inhibit
asfv
infect
target
viral
dna
replic
order
prove
idea
perform
imag
cytometri
quantifi
asfv
dna
viral
factori
fig
signific
reduct
p
amount
viral
dna
found
asfvinfect
cell
expos
genistein
hpi
fig
moreov
decreas
viral
dna
higher
p
asfvinfect
cell
treat
genistein
hpi
result
suggest
viral
dna
synthesi
impair
presenc
genistein
know
genistein
reduc
viral
yield
also
investig
whether
asfv
protein
synthesi
block
detect
express
earli
late
viral
protein
via
western
blot
result
show
synthesi
protein
significantli
reduc
follow
treatment
genistein
inhibit
occur
dosedepend
manner
fig
togeth
data
indic
genistein
inhibit
postentri
stage
asfv
lifecycl
asfv
encod
protein
type
ii
topoisomeras
topo
ii
activ
coelho
et
al
previou
studi
show
genistein
inhibit
activ
asfvtopo
ii
heterolog
express
saccharomyc
cerevisia
coelho
et
al
studi
effect
genistein
asfvtopo
ii
viral
infect
use
singl
cell
electrophoresi
analysi
comet
assay
fig
shown
fig
presenc
asfv
genistein
alon
combin
togeth
contribut
dna
damag
comparison
noninfect
nonexpos
control
cell
p
p
howev
dna
fragment
three
four
time
higher
asfvinfect
cell
expos
genistein
intermediatel
phase
infect
p
character
increas
rate
viral
dna
replic
rojo
et
al
character
like
interact
genistein
asfvtopo
ii
perform
molecular
dock
analysi
absenc
avail
xray
crystal
structur
asfvtopo
ii
construct
asfv
topo
ii
homolog
model
base
structur
close
homologu
homolog
model
follow
process
reliabl
verif
asfvtopo
ii
model
tertiari
structur
stereochem
correct
protein
carri
result
test
visual
ramachandran
plot
fig
sinc
topo
ii
two
mg
ion
cofactor
per
subunit
two
mg
ion
dock
obtain
asfvtopo
ii
model
obtain
asfvtopo
ii
tertiari
structur
model
complex
two
mg
ion
proteinprotein
dock
obtain
model
carri
crystal
structur
dna
topoisomeras
ii
dimer
saccharomyc
cerevisia
pdb
use
object
evalu
result
proteinprotein
dock
model
obtain
asfvtopo
ii
dimer
structur
model
lowest
interact
energi
kcalmol
lowest
rmsd
compar
structur
chosen
best
one
structur
best
obtain
asfvtopo
ii
dimer
model
complex
four
mg
ion
solvat
water
shell
thick
around
system
neutral
cl
na
mg
ion
concentr
mm
size
result
system
atom
asfvtopoiia
asfvtopoiib
h
na
cl
mg
result
system
subject
step
sd
minim
algorithm
step
abnr
minim
algorithm
energi
obtain
system
kcalmol
final
asfvtopo
ii
dimer
model
present
fig
dock
analysi
select
amino
acid
atpbind
site
amino
acid
possibl
interact
site
genistein
top
rank
model
base
smallest
icm
score
valu
visual
analysi
shown
snapshot
plot
genistein
interact
side
chain
asfvtopo
ii
dimer
model
fig
genistein
form
hydrogen
bond
atpbind
site
residu
bind
energi
valu
reveal
genistein
bound
atpbind
site
kcalmol
affin
compar
atp
kcalmol
tabl
fig
suggest
genistein
could
effect
compet
atp
bind
site
sinc
atpbind
site
residu
conserv
among
differ
asfv
strain
fig
expect
genistein
antivir
effect
asfv
strain
therefor
conduct
addit
experi
test
inhibitori
activ
genistein
virul
asfv
strain
porcin
macrophag
natur
host
cell
shown
fig
genistein
inhibit
asfv
infect
dosedepend
manner
effect
concentr
lower
p
ic
genistein
asfv
strain
higher
ic
si
report
asfv
agreement
previou
observ
strongest
reduct
log
viral
titer
found
genistein
treatment
initi
hpi
p
fig
antivir
effect
less
pronounc
genistein
ad
earli
late
replic
cycl
virucid
antientri
activ
observ
data
shown
final
signific
decreas
p
amount
viral
dna
asfv
factori
observ
asfvinfect
macrophag
expos
genistein
hpi
fig
thu
antivir
activ
genistein
asfv
strain
similar
effect
asfv
strain
order
explor
antivir
effect
genistein
express
three
viral
gene
investig
compar
nontreat
treat
asfvinfect
porcin
macrophag
fig
b
sever
reduct
viral
transcript
activ
detect
genisteintr
macrophag
hpi
onward
viral
transcript
decreas
hpi
fig
parallel
immunoblot
analysi
show
genistein
also
disrupt
viral
protein
synthesi
particular
translat
late
viral
protein
fig
probabl
hpi
alreadi
synthet
corrobor
result
obtain
vero
cell
year
larg
number
vaccin
test
asfv
howev
none
taken
forward
commerci
product
zakaryan
revilla
aria
et
al
context
conduct
antivir
screen
differ
compound
develop
effect
antivir
therapeut
hakobyan
et
al
hakobyan
et
al
one
compound
genistein
shown
inhibit
replic
differ
virus
divers
mechan
instanc
genistein
inhibit
human
cytomegaloviru
via
block
viral
immediateearli
protein
function
ever
et
al
pichind
viru
disrupt
activ
viral
transcript
vero
cell
vela
et
al
addit
genistein
shown
suppress
replic
avian
leukosi
viru
subgroup
j
inhibit
viru
transcript
qian
et
al
genistein
also
inhibit
hiv
infect
block
viral
protein
u
believ
form
ionic
channel
infect
cell
sauter
et
al
previous
report
asfv
sensit
genistein
though
concentr
toxic
studi
hakobyan
et
al
differ
nontox
concentr
explain
previous
use
method
measur
cytotox
crystal
violet
assay
less
sensit
mtt
use
studi
demonstr
genistein
concentr
exhibit
signific
antivir
properti
asfv
infect
vitro
vero
cell
porcin
macrophag
antivir
assay
reveal
virucid
effect
extracellular
asfv
particl
well
interfer
viral
attach
intern
step
furthermor
pretreat
vero
cell
genistein
also
fail
inhibit
asfv
infect
suggest
compound
affect
host
effector
regulatori
factor
signific
differ
compar
control
denot
p
p
p
result
indic
genistein
target
postentri
stage
asfv
infect
also
support
fact
genistein
show
higher
effici
ad
hpi
time
point
coincid
initi
cytoplasm
phase
viral
dna
replic
et
al
rojo
et
al
et
al
therefor
assum
genistein
could
interfer
process
reason
quantifi
dna
content
viral
factori
use
imag
cytometri
reduct
asfv
dna
genisteintr
cell
suggest
compound
inhibit
viral
dna
replic
scenario
support
reduct
viral
gene
express
absenc
late
viral
protein
porcin
macrophag
vero
cell
expos
genistein
sinc
known
express
late
viral
gene
occur
presenc
viral
dna
replic
inhibitor
sala
rapid
metabol
inactiv
short
halflif
genistein
may
explain
inhibitori
effect
dna
replic
viral
yield
less
profound
ad
earli
time
postinfect
chang
et
al
yang
et
al
current
sever
flavonoid
inhibit
dna
rna
viru
target
enzym
involv
genom
replic
transcript
exampl
quercetin
myricetin
strong
inhibitor
hiv
revers
transcriptas
ono
et
al
wogonin
shown
suppress
duck
hepat
b
viru
dhbv
dna
polymeras
infect
duck
guo
et
al
furthermor
myricetin
scutellarein
inhibit
sarscoronaviru
infect
affect
atpas
activ
viral
helicas
protein
yu
et
al
howev
knowledg
evid
genistein
may
inhibit
viral
infect
interact
enzym
involv
process
viral
dna
rna
replic
although
earli
data
suggest
genistein
may
stabil
complex
topo
ii
dna
therebi
induc
topo
iimedi
doublestrand
breakag
kiguchi
et
al
recent
coelho
et
al
show
genistein
concentr
inhibit
activ
recombin
asfvtopo
ii
purifi
yeast
base
observ
hypothes
genistein
interrupt
asfv
dna
replic
inhibit
viral
topo
ii
therefor
expect
signific
induct
dna
doublestrand
break
asfvinfect
genisteintr
cell
expect
genistein
found
significantli
induc
dna
fragment
particularli
late
phase
hpi
infect
phase
character
high
rate
asfv
dna
synthesi
vero
cell
rojo
et
al
thu
inhibit
asfvtopo
ii
need
viral
genom
replic
caus
dramat
increas
topo
iimedi
doublestrand
break
hypothesi
sustain
molecular
dock
analysi
base
fact
member
topo
ii
famili
highli
conserv
protein
forterr
gadel
forterr
et
al
construct
asfvtopo
ii
homolog
model
two
mg
ion
identifi
genistein
may
interact
four
amino
acid
residu
predict
atpbind
site
higher
bind
affin
atp
topo
ii
enzym
catalyz
chang
dna
topolog
reaction
coupl
hydrolysi
atp
bate
maxwel
although
unclear
topo
ii
consum
atp
support
reaction
requir
energi
input
propos
energi
atp
hydrolysi
need
control
separ
proteinprotein
interfac
prevent
accident
format
doublestrand
break
bate
et
al
therefor
atpcompetit
inhibitor
like
genistein
increas
rate
dna
fragment
upon
treatment
hand
competit
atpbind
site
inhibit
rate
enzymecatalyz
atp
hydrolysi
inde
earli
studi
show
genistein
potent
inhibitor
topo
iimedi
atp
hydrolysi
drosophila
melanogast
kc
tissu
cultur
cell
robinson
et
al
suggest
dock
result
accord
earlier
find
sinc
atpbind
site
topo
ii
highli
conserv
among
asfv
strain
genistein
competit
inhibitor
potent
antivir
virul
strain
current
circul
africa
eastern
europ
show
genistein
highli
effect
avirul
asfv
strain
also
asfv
strain
caus
mortal
domest
pig
thu
asfvtopo
ii
enzym
may
excel
target
antiasfv
agent
suppos
greater
effort
focu
develop
effect
antivir
drug
appli
treat
infect
pig
thu
control
spread
infect
develop
drug
pig
health
necessari
balanc
level
compound
antivir
activ
cost
prepar
compound
therefor
natur
compound
like
genistein
center
attent
due
high
avail
low
cost
side
effect
fig
genistein
inhibit
viral
transcript
protein
synthesi
macrophag
infect
strain
qrtpcr
analysi
earli
viral
gene
two
late
gene
differ
time
point
infect
porcin
macrophag
asfv
isol
moi
b
viral
gene
express
analysi
viral
transcript
asfvinfect
porcin
macrophag
treat
genistein
hpi
h
mockinfect
macrophag
use
control
assay
result
shown
averag
standard
error
se
number
molecul
viral
gene
number
molecul
housekeep
gene
cyclophilin
result
obtain
three
independ
experi
c
viral
protein
synthesi
analyz
nontreat
genisteintr
porcin
macrophag
hpi
molecular
weight
kda
evalu
viral
protein
indic
left
immunoblot
imag
use
load
control
